Embelin inhibits abdominal aortic aneurysm through decreasing IL-6-induced STAT3 and NF-?B inactivation

13Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to investigate the effect of embelin on abdominal aortic aneurysm (AAA). AAA model mice were induced by chronic infusion of 1,000 ng/kg/min Angiotensin II. AAA model mice were treated with 25, 50 or 100 mg/kg embelin for 28 days. Embelin inhibited tumor necrosis factor-a, interleukin (IL)-1ß, IL-6, IL-18 and malondialdehyde (MDA) level activities, increased superoxide dismutase, glutathione (GSH) and GSH peroxidase level activities and inhibited MDA level activities in AAA mice Embelin suppressed the secretion of matrix metalloproteinase-9 protein expression, monocyte chemoattractant protein-2 activity and epithelial neutrophil-activating peptide expression levels in AAA mice. Embelin suppressed phosphorylated-signal transducer and activator of transcription (STAT) 3, phosphorylated-p38 mitogen-activated protein kinase and nuclear factor (NF)-?B protein expression in AAA mice. These findings indicate that embelin inhibits AAA through decreasing IL-6-induced STAT3, and NF-?B inactivation.

Cite

CITATION STYLE

APA

Liu, Q., Wang, Q., & Li, H. (2018). Embelin inhibits abdominal aortic aneurysm through decreasing IL-6-induced STAT3 and NF-?B inactivation. Molecular Medicine Reports, 18(2), 2365–2372. https://doi.org/10.3892/mmr.2018.9221

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free